Under the Spotlight of GLP-1, the Hidden Risks of Eli Lilly’s High Valuation Cannot Be Ignored Life Science
Signs of Bitcoin Stabilization Emerging? Goldman Sachs and Multiple Institutions Bullish on Outlook Cryptocurrency, Technology
From NVIDIA to Broadcom, the AI Chip Battlefield Is Ablaze with Competition Consumer Goods, Technology
Tech Stocks Pull Back Nearly 10%. These 3 Dividend Stocks Have Become the Market’s Safe Haven Energy, Real Estate, Technology
Apple Plans to Open Siri to Third-Party AI Assistants, Strengthening iPhone’s Position as an AI Platform Technology
Retail Investors Reduce Nvidia Holdings for the First Time; Historical Patterns Suggest a Rebound May Be Approaching? Technology
The Halo of Gold Stocks Fades, Newmont and Barrick Mining May Present a Strategic Opportunity After Deep Correction Mining, Precious Metals
After Five Years of Sluggish Performance, Pfizer Finds Renewed Hope in High Dividends and Clinical Data Life Science
A Pullback or a Buying Opportunity? Analyzing Vertex Pharmaceuticals’ Growth Drivers for the Coming Year Life Science
Changes in the Dollar’s Trend, Morgan Stanley Predicts Weakening Later This Year Consumer Goods, Financial Service
